Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Anxiety in Patients with Schizophrenia: Epidemiology and Management
Henk Temmingh,
Dan J. Stein
Research output
:
Contribution to journal
›
Article
›
peer-review
118
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anxiety in Patients with Schizophrenia: Epidemiology and Management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Patients with Schizophrenia
100%
Epidemiology
100%
Anxiety Symptoms
100%
Schizophrenia
83%
Anxiety Disorders
50%
Positive Symptoms
33%
Pharmacotherapy
33%
Responsivity
16%
Posttraumatic Stress Disorder
16%
Cognitive Impairment
16%
Clinical Management
16%
Randomized Controlled Trial
16%
Acute Phase
16%
Clinical Presentation
16%
Cytochrome P450 (CYP450)
16%
Obsessive-compulsive Disorder
16%
Psychotherapy
16%
Antipsychotics
16%
Diagnostic Performance
16%
Randomized Trial
16%
Generalized Anxiety
16%
Schizophrenic Patients
16%
Psychosis
16%
Clinical Diagnosis
16%
Olanzapine
16%
Quetiapine
16%
Neurobiology
16%
Suicidality
16%
Brain-derived Neurotrophic Factor
16%
Selective Serotonin Reuptake Inhibitors
16%
Risperidone
16%
QT Prolongation
16%
Social Anxiety Disorder
16%
Pregabalin
16%
Disorder-specific
16%
Akathisia
16%
Psychotic Symptoms
16%
Medical Service Utilization
16%
Neutral Stimuli
16%
Screening Questions
16%
Aripiprazole
16%
Serotonin Transporter Gene
16%
Social Anxiety Symptoms
16%
Trifluoperazine
16%
Obsessive-compulsive
16%
Comorbid Anxiety
16%
Comorbid Anxiety Disorders
16%
Buspirone
16%
Internalizing Symptoms
16%
Emotional Communication
16%
Externalizing Symptoms
16%
Serotonin 1A
16%
Self-report Instrument
16%
Fear Circuit
16%
Underactive
16%
Emotional Expressivity
16%
Neuroscience
Positive Syndrome
100%
Anxiety Disorder
100%
Drug Therapy
100%
Posttraumatic Stress Disorder
50%
Randomized Controlled Trial
50%
Obsessive-Compulsive Disorder
50%
Cognitive Disorders
50%
Olanzapine
50%
Quetiapine
50%
Serotonin
50%
Neuroscience
50%
Cytochrome P450
50%
Social Anxiety Disorder
50%
Selective Serotonin Reuptake Inhibitor
50%
Risperidone
50%
Pregabalin
50%
Aripiprazole
50%
Serotonin Transporter
50%
Trifluoperazine
50%
Buspirone
50%
Akathisia
50%
Receptor
50%